We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Multiple Sclerosis Detected by Analysis of Exhaled Breath

By LabMedica International staff writers
Posted on 23 Aug 2012
A sensor array has been developed that can diagnose multiple sclerosis (MS) from exhaled breath.

Scientists identified volatile organic compounds from exhaled breath that can be associated with MS. Based on these findings they developed a sensor array that can diagnose MS by analyzing the compounds that appear in the breath of MS patients. The cross-reactive array of polycyclic aromatic hydrocarbons and single wall carbon-nanotube bilayers were designed for the detection of volatile organic compounds (hexanal and 5-methyl-undecane) that identify the presence of disease in the exhaled breath of patients with MS.

Using the sensors, the scientists carried out a proof-of-concept clinical study on 34 MS patients and 17 healthy volunteers and found that the developed sensors are just as accurate as a lumbar puncture but without the pain or the risk of side effects. Results obtained from the study showed that the sensors could discriminate between MS and healthy states from exhaled breath samples with 85.3% sensitivity, 70.6% specificity, and 80.4% accuracy.

Initiator and coordinator of the study, Prof. Hossam Haick at the department of chemical engineering and Russell Berrie Nanotechnology Institute, Technion–Israel Institute of Technology (Haifa, Israel) and colleagues report that doctors currently diagnose MS according to clinical symptoms, which include muscle spasms, numbness, coordination problems, and slurred speech. Confirmation of the diagnosis is made by either magnetic resonance imaging (MRI), which is costly, or lumbar puncture, which is invasive and can be painful with unpleasant side effects.


The study was published in the journal ACS Chemical Neuroscience in 2012.

Related Links:

Technion–Israel Institute of Technology




New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
ESR Analyzer
TEST1 2.0
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G

Latest Clinical Chem. News

Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation
23 Aug 2012  |   Clinical Chem.

Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear
23 Aug 2012  |   Clinical Chem.

New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
23 Aug 2012  |   Clinical Chem.



PURITAN MEDICAL